Gevo, Inc. (GEVO) Stock Price & Analysis
Gevo, Inc. (GEVO) fell 11.20% to USD 1.63 as of July 25, 2026 at 03:47 UTC, according to Nexqual real-time market data.
GEVO last closed at USD 1.83; the session ranged USD 1.61–1.83 on volume of 4,170,272 shares. Market capitalization is $395.54M, with a 52-week range of USD 1.12–2.97 (NCM). Source: Nexqual, July 25, 2026 at 03:47 UTC.
Key Statistics (as of July 25, 2026 at 03:47 UTC)
| Price | USD 1.63 |
|---|---|
| Change | ▼ 11.20% (down) |
| Previous Close | USD 1.83 |
| Open | USD 1.81 |
| Day Range | USD 1.61 – 1.83 |
| 52-Week Range | USD 1.12 – 2.97 |
| Volume | 4,170,272 shares |
| Market Cap | $395.54M |
| Exchange | NCM |
Technical Analysis (GEVO)
Nexqual's technical model rates GEVO "BUY" based on 4 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 03:47 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 51.73 (neutral) |
| vs SMA50 | Above (USD 1.59) |
| MACD | 0.04 (positive) |
Analyst Ratings (GEVO)
Wall Street analysts rate GEVO "Buy" based on 4 analysts, with a mean price target of USD 5.39 (range USD 1.8–14), per Nexqual as of July 25, 2026 at 03:47 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 4 |
| Mean Target | USD 5.39 |
| High Target | USD 14 |
| Low Target | USD 1.8 |
| Buy / Hold / Sell | 2 / 2 / 0 |
Earnings (GEVO)
| Next Earnings Date | 2026-08-06 |
|---|---|
| EPS Estimate | USD -0.01 |
| Revenue Estimate | $45.08M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD -0.09 vs est -0.02 ▼ miss |
| 2025-12-31 | USD -0.02 vs est -0.03 ▲ beat |
| 2025-09-30 | USD -0.03 vs est -0.06 ▲ beat |
| 2025-06-30 | USD 0.01 vs est -0.06 ▲ beat |
Source: Nexqual, July 25, 2026 at 03:47 UTC.
Financials & Fundamentals (GEVO)
| Total Revenue | $174.42M |
|---|---|
| Revenue Growth (YoY) | +47.50% |
| Gross Margin | +45.77% |
| Operating Margin | -11.40% |
| Profit Margin | -19.38% |
| ROE | -6.93% |
| Debt / Equity | 37.44 |
| Current Ratio | 4.31 |
| Total Cash | $78.90M |
| Total Debt | $170.23M |
| Free Cash Flow | $-10.52M |
Source: Nexqual, July 25, 2026 at 03:47 UTC.
Financial Health Score (GEVO)
Nexqual rates Gevo, Inc.'s overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 03:47 UTC.
| Growth | Strong — Revenue +849% YoY (annual) |
|---|---|
| Profitability | Mixed — Gross margin 46%, operating -11% |
| Balance Sheet | Strong — $79M cash vs $170M debt |
| Cash Flow | Weak — FCF negative: -$11M, burning cash |
| Efficiency | Critical — ROE -7%, ROA -0.8% |
Ownership (GEVO)
| Insider Ownership | +4.41% |
|---|---|
| Institutional Ownership | +37.09% |
| Shares Outstanding | 243.41M |
| Float | 225.81M |
| Short % of Float | +10.75% |
Source: Nexqual, July 25, 2026 at 03:47 UTC.
Leadership (GEVO)
Gevo, Inc. is led by Paul D. Bloom (age 51), CEO, President & Director, per Nexqual as of July 25, 2026 at 03:47 UTC.
| CEO, President & Director | Paul D. Bloom (age 51) |
|---|---|
| Chief Financial Officer | Oluwagbemileke Agiri (age 39) |
| Chief Marketing, Customer & Brand Officer | Andrew L. Shafer (age 63) |
| Vice President of Finance & Strategy | Eric Frey |
Major Backers & Investors (GEVO)
Notable institutional backers of Gevo, Inc. include Invesco, Goldman Sachs, Fidelity, according to Nexqual as of July 25, 2026 at 03:47 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Invesco | 3.47% |
| Goldman Sachs | 1.59% |
| Fidelity | 1.46% |
| First Bank & Trust | 1.26% |
| Renaissance Technologies | 0.91% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 11.33% |
| BlackRock | 10.24% |
| State Street | 7.26% |
| Geode Capital | 2.42% |
| Nuveen | 1.48% |
Source: Nexqual, July 25, 2026 at 03:47 UTC.
From Gevo, Inc.'s Latest SEC 10-K Filing (filed 2026-03-05)
Key Strengths & Strategy (as disclosed to the SEC)
- Gevo, Inc. operates as a carbon abatement company.
- It operates in four segments: Gevo, GevoFuels, GevoRNG, and GevoND.
- The company offers sustainable aviation fuel, motor fuels, and chemicals and materials; certain specialty fuels, on-road fuels, and certain products for the food chain comprising protein and feeds; hydrocarbons for gasoline, racing fuel blend stocks, and diesel fuel; ethylene and butenes; plastics and materials; and renewable natural gas, isobutanol, and isooctane.
- It is also involved in development, construction, and operation of Alcohol-to-Jet projects; provision of GevoRNG, a project which leverages anaerobic digestion technology to capture and convert methane emissions into renewable natural gas; and operates Verity platform that tracks, measures, and verifies various attributes throughout the supply chain.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BNGO | Bionano Genomics, Inc. | USD 1.11 | ▼ 0.89% |
| NNDM | Nano Dimension Ltd. | USD 1.47 | ▼ 0.68% |
| OCGN | Ocugen, Inc. | USD 1.21 | ▼ 6.2% |
| SENS | Senseonics Holdings, Inc. | USD 4.86 | ▲ 0% |
| FCEL | FuelCell Energy, Inc. | USD 21.26 | ▼ 5.38% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:47 UTC. This page is informational and not investment advice.